ArticleDigital health
Test-retest reliability of the computer-based cognitive assessment tool for community-dwelling older adults in Japan: The Otassha study.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intra- and Inter-Rater Reliability Analysis of MMSE-K and Tablet PC-Based MMSE-K Kit in Patients with Neurologic Disease.Healthcare (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Early detection of dementia is crucial for effective intervention. The computer-based cognitive assessment tool (CompBased-CAT) was designed to assess cognitive function using a tablet computer. While its predictive validity for mild cognitive impairment (MCI) is established, its test-retest reliability remains unclear. This study aimed to evaluate the test-retest reliability of CompBased-CAT among older Japanese adults in a community setting. Methods: This is a methodological study that examined the test-retest reliability of CompBased-CAT. Community-dwelling older adults aged 65 years or older who participated in both the pre-test and post-test were included. Pre-test assessments were conducted during the 2023 Otassha study from 28 September to 8 October 2023, with the post-test administered 62 days (±14 days) later. Subtest scores were normalized to Results: A total of 80 participants (mean age: 76.8 years; 27.5% male) were analyzed. Paired Conclusion: CompBased-CAT demonstrated good test-retest reliability, with an ICC of 0.64 among all participants, which increased to 0.74 among participants with MCI over a 2-month period, indicating its potential for monitoring cognitive function through repeated assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.